Table 2. Postoperative Clinical Outcomes in the Two Study Groups.
Variable | Control group | IV-FCM group | p-value |
---|---|---|---|
Perioperative blood loss (mL) | 815 ± 666 | 915 ± 508 | 0.143 |
No. of patients transfused | 92 (61) | 70 (47) | NA |
No. of units transfused (pack) | 1.7 ± 2.7 | 1.0 ± 1.2 | 0.002* |
Length of hospital stay (day) | 11.8 ± 10.3 | 7.6 ± 3.3 | 0* |
Follow-up period (mo) | 33.3 ± 23.4 | 20.7 ± 12.0 | 0* |
Postsurgical complication | 6 (3) | 7 (4) | NA |
Periprosthetic joint infection | 1 | 1 | NA |
Urinary tract and upper respiratory infections | 5 | 4 | NA |
Venous thromboembolism | 0 | 2 | NA |
Values are presented as mean ± standard deviation or number (%).
IV-FCM: intravenous ferric carboxymaltose, NA: not significant.
*p-value < 0.05.